Vagisil Anti-itch Medicated Creme Maximum Strength Cream
NDC Package 11509-4402-1
Package Information
Vagisil Anti-itch Medicated Creme Maximum Strength (benzocaine and resorcinol) cream is adults and children 12years and older apply a fingertip amount (approximately 1-inch strip) to affected area not more than 3 to 4 times daily. This formulation utilizes a cream delivery system. Marketed by Combe Incorporated, this product is identified by NDC 11509-4402 and is authorized under FDA application M017.
Identification & Billing
- RxCUI: 1247441 - Vagisil Maximum Strength 20 % / 3 % Vaginal Cream
- RxCUI: 1247441 - benzocaine 200 MG/ML / resorcinol 30 MG/ML Vaginal Cream [Vagisil Original Formula]
- RxCUI: 1247441 - Vagisil Maximum Strength (benzocaine 20 % / resorcinol 3 % ) Vaginal Cream
- RxCUI: 1247441 - Vagisil, Maximum Strength, Anti-Itch Topical Cream
- RxCUI: 637518 - benzocaine 20 % / resorcinol 3 % Vaginal Cream
Clinical Specifications
Regulatory & Marketing
Hierarchy Structure
- 11509 - Combe Incorporated
- 11509-4402 - Vagisil Anti-itch Medicated Creme Maximum Strength
- 11509-4402-1 - 1 TUBE in 1 CARTON / 28 g in 1 TUBE
- 11509-4402 - Vagisil Anti-itch Medicated Creme Maximum Strength
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 11509-4402-1 identifies a specific commercial package of 1 tube in 1 carton / 28 g in 1 tube of Vagisil Anti-itch Medicated Creme Maximum Strength, a human over the counter drug labeled by Combe Incorporated. This product is billed per "GM" gram and contains an estimated amount of 28 billable units per package. This cream is formulated for topical use and contains benzocaine; resorcinol as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Combe Incorporated on March 01, 1995. The current certification is valid through December 31, 2026.
How is this Combe Incorporated product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 11509440201. Quantities are measured in per "gm or gram", products billed per gram are products measured by weight.. There are 28 total billable units per package. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Package segment to maintain the 5-4-2 structure.